Aristides Capital’s Inogen INGN Stock Holding History

Aristides Capital’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,121	Closed	-$276K	–	237
2021 Q4	$276K	Buy	+8,121	New	+$295K	0.13%	158

Other funds holding INGN

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Aristides Capital's INGN Position: Q1 2022 in Review

Aristides Capital sold out of Inogen (INGN) in Q1 2022, closing a stake of 8,121 shares — an estimated $276K sold.

Aristides Capital first reported a position in INGN in Q4 2021 and held it in 1 quarter. The position peaked at $276K in Q4 2021. 149 funds tracked by Wall St. Rank hold INGN as of Q1 2022.

Aristides Capital reported no remaining Inogen position as of Q1 2022 after selling out during the quarter.
Aristides Capital sold 8,121 Inogen shares in Q1 2022, an estimated $276K.
Aristides Capital first reported a position in Inogen in Q4 2021 and held it in 1 quarter.
Aristides Capital's Inogen position peaked at $276K in Q4 2021.
149 funds tracked by Wall St. Rank held Inogen as of Q1 2022.

Based on Aristides Capital's 13F filing for Q1 2022, filed 16 May 2022.